#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fungal infection Gaucher's disease type III Oesophageal squamous cell carcinoma stage III Alveolar proteinosis Neoplasm Angelman's syndrome Peritoneal mesothelioma malignant Malignant central nervous system neoplasm Heavy menstrual bleeding Hyperchylomicronaemia Wolfram syndrome Autoimmune myositis Haemophilia B without inhibitors Dermatitis Drug eruption More trials…

    Learn about Rare Diseases

    Familial haemophagocytic lymphohistiocytosis Erdheim-Chester disease – Diagnostics Wiskott-Aldrich syndrome – Trials in Disease Primary immunodeficiency syndrome Marginal zone lymphoma refractory Loeys-Dietz syndrome – Treatment Cerebral arteriovenous malformation haemorrhagic – Life with Disease Castleman’s disease – Diagnostics Optic glioma – Treatment Anaplastic thyroid cancer More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Teverelix Atorvastatin Opevesostat Urapidil Ertugliflozin Leuprorelin Acetate Pegunigalsidase Alfa Gadobutrol Sonidegib Namilumab Ribitol Murcidencel S227928 Fluorodopa (18F) Deutivacaftor Prednisone Odm-111 Fidanacogene Elaparvovec Sultiame Betahistine Dihydrochloride More therapies…

    Learn about Your Condition

    Cytomegalovirus infection Pulmonary hypertension Ischaemic skin ulcer Vascular calcification Herpes zoster Cognitive disorder Measles Infant sedation Meningioma malignant Nephrolithiasis Neurodermatitis Ependymoma malignant Neurodegenerative disorder Osteochondrodysplasia Primary biliary cholangitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Safety and Feasibility of Bevacizumab-800CW Imaging for Patients with Barrett’s Esophagus, Colon Cancer, or Gastrointestinal Dysplasia

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Barrett’s oesophagus
    • Colon cancer
    Investigated Drugs:
    • Bevacizumab
    The Netherlands

  • Study on Coronary Artery Disease: Evaluating Myocardial Blood Flow Using SYN2, Regadenoson, and Adenosine in Patients with Heart Conditions

    Recruiting

    2 1 1 1 1
    Investigated Diseases:
    • Coronary artery disease
    Investigated Drugs:
    • Regadenoson
    • Syn2
    • Adenosine
    Poland

  • Study on Nipocalimab for Reducing Risk of Fetal and Neonatal Alloimmune Thrombocytopenia in At-risk Pregnancies

    Recruiting

    3 1
    Investigated Drugs:
    • Nipocalimab
    Belgium France Germany Hungary Italy The Netherlands +5

  • Study on Reducing Bleeding Risk in Heart Attack Patients Using Clopidogrel, Ticagrelor, and Prasugrel After Stent Procedure

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Myocardial infarction
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Clopidogrel
    • Prasugrel
    Denmark

  • Comparison of Furosemide, Nitrates, or Their Combination for Initial Treatment of Pulmonary Congestion in Patients with Acute Heart Failure

    Recruiting

    3 1 1
    Investigated Diseases:
    • Pulmonary congestion
    • Cardiac failure acute
    Investigated Drugs:
    • Furosemide
    • Isosorbide Dinitrate
    Denmark

  • Study on the Effects of Xenon and Oxygen on Brain Injury and Recovery in Patients with Aneurysmal Subarachnoid Hemorrhage in Intensive Care

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Xenon
    • Oxygen
    Finland
Previous Page
1 … 567 568 569 570 571 … 1,654
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!